Antibody evasion by the P.1 strain of SARS-CoV-2
Terminating the SARS-CoV-2 pandemic relies upon pan-global vaccination. Current vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates. However, new strains have emerged with multiple mutations, including P.1 from Brazil, B.1.351 from South Africa, and B.1.1.7...
Автори: | Dejnirattisai, W, Zhou, D, Supasa, P, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Tuekprakhon, A, Nutalai, R, Wang, B, López-Camacho, C, Slon-Campos, J, Walter, TS, Skelly, D, Costa Clemens, SA, Naveca, FG, Nascimento, V, Nascimento, F, Fernandes da Costa, C, Resende, PC, Pauvolid-Correa, A, Siqueira, MM, Dold, C, Levin, R, Dong, T, Pollard, AJ, Knight, JC, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, SC, Carroll, MW, Klenerman, P, Barnes, E, Dunachie, SJ, Paterson, NG, Williams, MA, Hall, DR, Hulswit, RJG, Bowden, TA, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Cell Press
2021
|
Схожі ресурси
Схожі ресурси
-
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
за авторством: Zhou, D, та інші
Опубліковано: (2021) -
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
за авторством: Liu, C, та інші
Опубліковано: (2021) -
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
за авторством: Supasa, P, та інші
Опубліковано: (2021) -
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
за авторством: Nutalai, R, та інші
Опубліковано: (2022) -
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
за авторством: Liu, C, та інші
Опубліковано: (2021)